BIOTECH ADVANTAGE

Lasne ·KBO/BCE: BE 0787.767.583

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-03-2025	31-10-2025	28-10-2025	3 d early	2025-00555846
31-03-2024	31-10-2024	16-10-2024	15 d early	2024-00508090
31-03-2023	31-10-2023	30-10-2023	1 d early	2023-00496351

Metric	This company	Sector median	Position in the sector
Solvency	86.2%	55.5%	better than 86% of 4723 sector peers
Net result	€233k	€38k	better than 95% of 4722 sector peers
Equity	€386k	€64k	better than 93% of 4723 sector peers
Gross operating margin	€305k	€61k	better than 95% of 4715 sector peers
Total assets	€448k	€146k	better than 85% of 4723 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€448k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€444k
Amounts receivable within one year	40/41	€127k
Cash & bank	54/58	€293k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€448k
Equity	10/15	€386k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€381k
Amounts payable	17/49	€62k
Amounts payable within one year	42/48	€60k
Trade debts payable within one year	44	€7k
Income statement
Gross operating margin	9900	€305k
Operating result	9901	€303k
Financial income	75	€2k
Financial charges	65	€439
Result before taxes	9903	€305k
Income taxes	67/77	€72k
Net result for the period	9904	€233k
Result to be appropriated	9905	€233k

Summary